CN101735151B - 氯尼达明的结晶形式i、其制备方法和含有所述结晶形式i的组合物 - Google Patents
氯尼达明的结晶形式i、其制备方法和含有所述结晶形式i的组合物 Download PDFInfo
- Publication number
- CN101735151B CN101735151B CN2009102611954A CN200910261195A CN101735151B CN 101735151 B CN101735151 B CN 101735151B CN 2009102611954 A CN2009102611954 A CN 2009102611954A CN 200910261195 A CN200910261195 A CN 200910261195A CN 101735151 B CN101735151 B CN 101735151B
- Authority
- CN
- China
- Prior art keywords
- lonidamine
- crystal
- acid
- crystalline
- amorphous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102611954A CN101735151B (zh) | 2005-08-17 | 2005-08-17 | 氯尼达明的结晶形式i、其制备方法和含有所述结晶形式i的组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102611954A CN101735151B (zh) | 2005-08-17 | 2005-08-17 | 氯尼达明的结晶形式i、其制备方法和含有所述结晶形式i的组合物 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005100288467A Division CN1915978B (zh) | 2005-08-17 | 2005-08-17 | 氯尼达明的结晶形式、其制备方法和含有所述结晶形式的组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101735151A CN101735151A (zh) | 2010-06-16 |
CN101735151B true CN101735151B (zh) | 2012-07-04 |
Family
ID=42459233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009102611954A Expired - Fee Related CN101735151B (zh) | 2005-08-17 | 2005-08-17 | 氯尼达明的结晶形式i、其制备方法和含有所述结晶形式i的组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101735151B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3895026A (en) * | 1972-02-29 | 1975-07-15 | Acraf | Substituted 1-benzyl-1h-indazole-3-carboxylic acids and derivatives thereof |
ES8607013A3 (es) * | 1985-07-29 | 1986-06-01 | Ausonia S A Lab | Procedimiento de preparacion de acidos 1-bencil-1h-indazol -3-carboxilicos sustituidos y sus derivados |
CN1594297A (zh) * | 2004-06-23 | 2005-03-16 | 上海复星朝晖药业有限公司 | 氯尼达明的合成方法 |
-
2005
- 2005-08-17 CN CN2009102611954A patent/CN101735151B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3895026A (en) * | 1972-02-29 | 1975-07-15 | Acraf | Substituted 1-benzyl-1h-indazole-3-carboxylic acids and derivatives thereof |
ES8607013A3 (es) * | 1985-07-29 | 1986-06-01 | Ausonia S A Lab | Procedimiento de preparacion de acidos 1-bencil-1h-indazol -3-carboxilicos sustituidos y sus derivados |
CN1594297A (zh) * | 2004-06-23 | 2005-03-16 | 上海复星朝晖药业有限公司 | 氯尼达明的合成方法 |
Non-Patent Citations (1)
Title |
---|
张万年等.《氯尼达明的合成》.《中国医药工业杂志》.1995,第26卷(第3期),103-104. * |
Also Published As
Publication number | Publication date |
---|---|
CN101735151A (zh) | 2010-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103889429B (zh) | Sglt2抑制剂的结晶和非结晶形式 | |
TWI285635B (en) | 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition | |
RU2010115089A (ru) | Малеатные соли (е)-n-{4-[3-хлор-4-(2-пиридинилметокси)анилино]-3-циано-7-этокси-6-хинолинил}-4-(диметиламино)-2-бутенамида и их кристаллические формы | |
HUE026983T2 (en) | 3- (2,6-Dichloro-3,5-dimethoxy-phenyl) -1- {6- [4- (4-ethyl-piperazin-1-yl) -phenylamino] -pyrimidin-4-yl-crystalline form 1-Methylurea and its salts | |
CN105837566A (zh) | (R)-7-氯-N-(奎宁环-3-基)苯并[b]噻吩-2-甲酰胺盐酸盐单水合物的晶型 | |
CN101277694B (zh) | 盐酸伊立替康的新晶形 | |
US8420672B2 (en) | Solid forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindo1-2-yl)-piperidine-2,6-dione and methods of making the same | |
CN101412700A (zh) | 非布司他的晶型及其制备方法 | |
CN102453024A (zh) | 一种尼罗替尼盐酸盐晶形及其制备方法 | |
CN106279127B (zh) | 阿法替尼酸加成盐及其晶型、其制备方法及药物组合物 | |
CN107849007A (zh) | 比拉斯汀的晶型及其制备方法 | |
CN101759644B (zh) | 氯尼达明的结晶形式iii、其制备方法和含有所述结晶形式iii的组合物 | |
CN1915978B (zh) | 氯尼达明的结晶形式、其制备方法和含有所述结晶形式的组合物 | |
CN103073542A (zh) | 一种枸橼酸托烷司琼晶型ⅱ的制备和应用 | |
CN101735151B (zh) | 氯尼达明的结晶形式i、其制备方法和含有所述结晶形式i的组合物 | |
WO2009037538A2 (en) | Process for the preparation of lamivudine form i | |
NO329315B1 (no) | Krystallmodifikasjon av forbindelse, farmasoytiske preparater inneholdende denne og anvendelse av krystallmodifikasjonen. | |
CN110172059B (zh) | 二苯并[b,e]氮杂-6,11-二酮三氮唑类化合物及其制备方法和应用 | |
NZ538966A (en) | Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate | |
CN105315198A (zh) | 一种吡非尼酮的晶型及其制备方法 | |
CN107118153A (zh) | 一种瑞戈非尼一水合物晶型及其制备方法 | |
CN101602764B (zh) | 一种阿昔洛韦2/3水合物的制备方法 | |
CN104557869B (zh) | 一种吡啶胺化合物富马酸盐的晶型 | |
CN103524416B (zh) | 一种塞来昔布新晶型a及其制备方法 | |
CN102977024B (zh) | 一种(-)-美普他酚苯氨基甲酸酯-l-(+)-酒石酸盐i型晶体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ZHEJIANG HONGGUAN BIOLOGICAL PHARMACEUTICAL CO., L Free format text: FORMER OWNER: HANGZHOU MINSHENG PHARMACEUTICAL CO., LTD. Effective date: 20150630 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150630 Address after: The high-tech West Road 314500 in Zhejiang Province, Tongxiang Economic Development Zone No. 518 Patentee after: Zhejiang Hongguan Bio-Pharma Co., Ltd. Address before: 310011 No. 108 Tong Road, Hangzhou, Zhejiang, Yuhang Patentee before: Hangzhou Minsheng Pharmaceutical Co., Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Crystalline form I of lonidamine, preparation method thereof and composite containing the same Effective date of registration: 20150722 Granted publication date: 20120704 Pledgee: Bank of Hangzhou Limited by Share Ltd Tongxiang branch Pledgor: Zhejiang Hongguan Bio-Pharma Co., Ltd. Registration number: 2015990000585 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120704 Termination date: 20170817 |
|
CF01 | Termination of patent right due to non-payment of annual fee |